The PI3K/AKT pathway promotes gefitinib resistance in wild-type EGFR lung adenocarcinoma by a deacetylase-dependent mechanism

作者： V. Jeannot , B. Busser , E. Brambilla , M. Wislez , B. Robin

DOI: 10.1016/J.RMR.2014.04.027

关键词: